SUCLG2 identified as both a determinator of CSF A beta(1-42) levels and an attenuator of cognitive decline in Alzheimer's disease - Ramírez, Alfredo; Frölich, Lutz (Human molecular genetics, 2014)
Gesehen am: 22.04.2015